Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.
3 reports, 1 independent
Updated Fri 00:00
No new developments lately
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
French pharmaceutical company
-
Morgan Stanley
U.S. investment bank
Related events
- Citigroup reaffirmed a neutral rating and Morgan Stanley reiterated an overweight rating on Siemens Energy AG, which is headquartered in Germany.
- Citigroup restated a buy rating on SAP shares, and Morgan Stanley reiterated an overweight rating on the company.
- Citigroup and Morgan Stanley released price target updates regarding Mercado Pago (MELI) stock.
- Jefferies downgraded a company to hold rating, while Citigroup reaffirmed neutral and Morgan Stanley reiterated overweight ratings on shares.
- Citigroup and Morgan Stanley are noted as major financial services players.